# Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

> **NCT03703492** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 12 (actual)

## Conditions studied

- Breast Cancer
- Ductal Carcinoma in Situ - Category

## Interventions

- **DRUG:** (18F)FES
- **DRUG:** Gadobenate dimeglumine

## Key facts

- **NCT ID:** NCT03703492
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-03
- **Primary completion:** 2024-01-02
- **Final completion:** 2024-01-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03703492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03703492, "Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03703492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*